Skip to main content
SpringerLink
Log in

COPD

Neue Fixkombi lindert nachhaltig

  • infopharm
  • Published:
Pneumo News Aims and scope

Neben dem Rauchstopp ist die inhalative Therapie bei COPD eine wichtige Maßnahme. Seit 2. Februar gibt es hier auch eine neu LAMA/LABA-Fixkombi aus Aclidiniumbromid und Formoterol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Geldmacher H et al. Dtsch Med Wochenschr. 2008:133(50):2609–14.

    Article  CAS  PubMed  Google Scholar 

  2. Singh D et al. BMC Pulm Med. 2014;14(1):178.

    Article  PubMed Central  PubMed  Google Scholar 

Quelle

  • Launch-Pressekonferenz, Frankfurt/Main, 29.01.2015; Veranstalter: AstraZeneca

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Katharina Grzegorek

Authors
  1. Katharina Grzegorek
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grzegorek, K. Neue Fixkombi lindert nachhaltig. Pneumo News 7, 67 (2015). https://doi.org/10.1007/s15033-015-0172-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-015-0172-1

Search

Navigation